Stay updated on CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.

Latest updates to the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdministrative site changes: a new revision (v3.4.2) and the removal of the prior government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedA site-wide notice about a lapse in government funding and operating status was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedA 'Show glossary' option is added and the page now displays 'Last Update Submitted that Met QC Criteria' with revision 3.4.0. The older label 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and revision 3.3.4 are removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor update with no impact on core content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Locations section with Maryland as a study site and removed the older Maryland Locations entry and HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0; no study content or critical UI changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.